• Contact Us
  • Indexing
  • Submit Manuscript
  • Open Access
  • Journals
  • Home
  • ISSN: 2373-9479
    Early Online
    Volume 6, Issue 1
    Research Article
    Charles H. Crawford, Jeffrey L. Gum, Lawrence G. Lenke, Jacob M Buchowski, Charles C. Edwards, Steven D. Glassman, and Leah Y. Carreon*
    In an effort to reduce the rate of Surgical Site Infections (SSIs), recent studies have reported using intrawound, topical vancomycin powder. Although cost-effective and promising results have been published, there is concern for development of antibiotic resistance and catastrophic superbug infections. The purpose of this study was to evaluate and compare the culture profile of Surgical Site Infection (SSI) in patients undergoing posterior lumbar instrumented fusions with topical vancomycin powder utilized versus controls prior to the use of topical vancomycin powder. Patients who had a posterior lumbar instrumented fusion and subsequently developed SSI requiring operative treatment from June 2007 to June 2008 and from June 2011 to June 2012 were identified. Standard demographic and surgical data were collected. Culture results and timing of the SSI relative to index surgery were also collected. Comparison of SSIs pre-vancomycin (2007-2008) and post-vancomycin (2011-2012) identified 31 versus 26 patients, respectively; no difference in demographic or surgical characteristics between time-dependent cohorts. There was no difference in the culture profile between groups (p=0.667). When comparing the culture profile of surgical site infections after posterior lumbar instrumented fusions, there appears to be no difference comparing a pre-Vancomycin interval versus a post-vancomycin interval. Additionally, comparing SSIs with or without topical vancomycin, regardless of time interval, showed no difference in culture profile. The results of this study suggest that topical vancomycin powder did not increase the incidence of vancomycin-resistant, super bug infections in the time period studied. Continued surveillance of this increasingly common practice is warranted.
  • Recent Articles
  • JSciMed Central welcomes back astronaut Scott Kelly and cosmonaut Mikhail Kornienko.

    Wonder Women Tech not only disrupted the traditional conference model but innovatively changed the way conferences should be held.

    JSciMed Central Peer-reviewed Open Access Journals
    10120 S Eastern Ave, Henderson,
    Nevada 89052, USA
    Tel: (702)-751-7806
    Toll free number: 1-800-762-9856
    Fax: (844)-572-4633 (844-JSCIMED)
    E-mail: JSMNS@jscimedcentral.com
    1455 Frazee Road, Suite 570
    San Diego, California 92108, USA
    Tel: (619)-373-8720
    Toll free number: 1-800-762-9856
    Fax: (844)-572-4633 (844-JSCIMED)
    E-mail: JSMNS@jscimedcentral.com
    About      |      Journals      |      Open Access      |      Special Issue Proposals      |      Guidelines      |      Submit Manuscript      |      Contacts
    Copyright © 2016 JSciMed Central All Rights Reserved
    Creative Commons Licence Open Access Publication by JSciMed Central is licensed under a Creative Commons Attribution 4.0 International License.
    Based on a work at https://jscimedcentral.com/. Permissions beyond the scope of this license may be available at https://creativecommons.org/.